KY-19382 is a novel, potent and orally active dual inhibitor of CXXC5-DVL( IC50s =19) and GSK3β( IC50s = 10 nM). It can be used for the research of high fat diet (HFD) induced metabolic diseases.

纯度：≥98%

CAS：2226664-93-1